NA
ENZ

NewEdge Advisors’s Enzo Biochem, Inc. ENZ Stock Holding History

NewEdge Advisors’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10
Closed -$13 – 4034
2024
Q1 		$13 Hold
10
– – ﹤0.01% 3773
2023
Q4 		$14 Hold
10
– – ﹤0.01% 3708
2023
Q3 		$14 Hold
10
– – ﹤0.01% 3434
2023
Q2 		$18 Hold
10
– – ﹤0.01% 3458
2023
Q1 		$24 Hold
10
– – ﹤0.01% 3383
2022
Q4 		$0 Buy
+10
New +$19 ﹤0.01% 4231

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
WIM
Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return

NewEdge Advisors's ENZ Position: Q2 2024 in Review

NewEdge Advisors sold out of Enzo Biochem, Inc. (ENZ) in Q2 2024, closing a stake of 10 shares — an estimated $13 sold.

NewEdge Advisors first reported a position in ENZ in Q4 2022 and held it in 6 quarters. The position peaked at $24 in Q1 2023. 39 funds tracked by Wall St. Rank hold ENZ as of Q2 2024.

  • NewEdge Advisors reported no remaining Enzo Biochem, Inc. position as of Q2 2024 after selling out during the quarter.
  • NewEdge Advisors sold 10 Enzo Biochem, Inc. shares in Q2 2024, an estimated $13.
  • NewEdge Advisors first reported a position in Enzo Biochem, Inc. in Q4 2022 and held it in 6 quarters.
  • NewEdge Advisors's Enzo Biochem, Inc. position peaked at $24 in Q1 2023.
  • 39 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2024.

Based on NewEdge Advisors's 13F filing for Q2 2024, filed 16 Aug 2024.